ESC 365 - Low-dose mineralocorticoid receptor antagonists improve outcomes without dose escalation in elderly TEER patients with systolic heart failure

ESC Professional Premium Access

Low-dose mineralocorticoid receptor antagonists improve outcomes without dose escalation in elderly TEER patients with systolic heart failure

Session: New perspectives in cardiology (4) - Interventions for structural disease and stroke

Topic: Mitral Valve Intervention

Speaker: Doctor T. Imamura (Toyama, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Teruhiko Imamura

University of Toyama, Toyama (Japan)

0 follower

9 more presentations in this session

Discussant - Interventions for structural disease and stroke

Outcome of cerebral embolic protection during transcatheter aortic valve replacement in high risk patients for stroke

Speaker: Doctor C. Nakai (Albany, US)

Anticoagulation timing after stroke in atrial fibrillation: evidence from a systematic review and meta-analysis

Speaker: Doctor I. Serag (Mansoura, EG)

Nickel sensitization or desensitization after patent foramen ovale closure

Speaker: Doctor A. Apostolos (Athens, GR)

Impact of left atrial appendage closure on events after intracranial haemorrhage in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry

Speaker: Doctor A. Reina (Seville, ES)

Access the full session

New perspectives in cardiology (4) - Interventions for structural disease and stroke

Speakers: Doctor T. Imamura, Doctor C. Nakai, Doctor I. Serag, Doctor A. Apostolos, Doctor A. Reina

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources